Evidence map›Paper›PMID 34874191›Full record

Observational studyCannabis and cannabinoid research2023

Cannabis-Responsive Biomarkers: A Pharmacometabolomics-Based Application to Evaluate the Impact of Medical Cannabis Treatment on Children with Autism Spectrum Disorder.

Michael Siani-Rose, Stephany Cox, Bonni Goldstein, Donald Abrams, Myiesha Taylor, Itzhak Kurek

Open access · hybridAbstract readObservational Study
In one paragraph

Observational study in Cannabis and cannabinoid research, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 24 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Michael Siani-RoseCannformatics, Inc., San Francisco, California, USA.
Stephany CoxCannformatics, Inc., San Francisco, California, USA.
Bonni GoldsteinCannformatics, Inc., San Francisco, California, USA.
Donald AbramsCannformatics, Inc., San Francisco, California, USA.
Myiesha TaylorCannformatics, Inc., San Francisco, California, USA.
Itzhak KurekCannformatics, Inc., San Francisco, California, USA.ORCID 0000-0002-5638-1119
Canon (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Autism Spectrum DisorderCannabisHallucinogensMedical MarijuanaBiomarkersCannabinoid Receptor AgonistsChildHumansLearningBiomarkersCannabinoid Receptor AgonistsHallucinogensMedical Marijuanaautismbiomarkerschildrenmedical cannabismetabolomicssaliva

Identifiers

PMID34874191
PMCPMC9940806
OpenAlexW4200100891

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.